BioNano Genomics Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.45. The key difference: Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | XDTE | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $4.92 | $44.76 |
52-Week Low | $1.06 | $36.00 |
Enterprise Value | $16.26M | — |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →